Nuclear Imaging of Hormonal Receptor Status in Breast Cancer: A Tool for Guiding Endocrine Treatment and Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|7|6|510-519

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.7, Iss.6, 2007-09, pp. : 510-519

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current status and future perspectives in the endocrine treatment of postmenopausal, hormone receptor-positive metastatic breast cancer

By Montemurro Filippo   Rossi Valentina   Geuna Elena   Valabrega Giorgio   Martinello Rossella   Milani Andrea   Aglietta Massimo  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. : 2143-2156

Informa Healthcare

Access to resources Recommend Favorite

Exogenous Hormonal Regulation in Breast Cancer Cells by Phytoestrogens and Endocrine Disruptors

By  

Current Medicinal Chemistry, Vol. 21, Iss. 9, 2014-03 ,pp. : 1129-1145

Bentham Science Publishers

Access to resources Recommend Favorite

Development of selective aryl hydrocarbon receptor modulators for treatment of breast cancer

By Safe S.   Qin C.   McDougal A.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 9, 1999-09 ,pp. : 1385-1396

Informa Healthcare

Access to resources Recommend Favorite

Non-Invasive Radiotracer Imaging as a Tool for Drug Development

By  

Current Pharmaceutical Design, Vol. 6, Iss. 10, 2000-07 ,pp. : 973-989

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of metabolizing enzymes on drug response of endocrine therapy in breast cancer

By Saladores Pilar H   Precht Jana C   Schroth Werner   Brauch Hiltrud   Schwab Matthias  

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 4, 2013-05 ,pp. : 349-365

Informa Healthcare

Access to resources Recommend Favorite